Podcast

Rapid Fire: Respirology (And welcome back Drs. Kieran Quinn and Emily Hughes!)

Welcome back Rounds Table Listeners!

For episode 5 we have two very special guests co-hosting.

Welcome back to Drs. Kieran Quinn and Emily Hughes. This episode they discuss 4 articles on all things Respirology.

Classic rapid fire format, let’s dive right in.

  1. Can the β-blocker, metoprolol, be used to prevent COPD exacerbations? (00:00 to 06:48) (https://www.nejm.org/doi/full/10.1056/NEJMoa1908142)
  2. What is the safety and efficacy of the monoclonal antibody, benralizumab – an IL5 inhibitor, in preventing COPD exacerbations? (06:49 to 10:12) (https://www.nejm.org/doi/full/10.1056/NEJMoa1905248)
  3. A new antibiotic for community acquired pneumonia: is treatment with oral lefamulin non-inferior to moxifloxacin? (10:20 to 16:22) (https://jamanetwork.com/journals/jama/article-abstract/2752331)
  4. What are the predictors and outcomes associated with excess duration of antibiotic treatment in patients hospitalized with pneumonia? (16:25 to 21:44)https://annals.org/aim/article-abstract/2737823/excess-antibiotic-treatment-duration-adverse-events-patients-hospitalized-pneumonia-multihospital

Last but not least, the Good Stuff:

  1. What you should know about severe lung illness related to vaping:

https://www.canada.ca/en/public-health/services/diseases/vaping-pulmonary-illness.html

  1. A meta-analysis metastasis; metanalysis are taking over medical literature:

https://jamanetwork.com/journals/jamainternalmedicine/article-abstract/2739053

 

Questions? Comments? Feedback? We’d love to hear from you. @roundstable

Leave a Comment

Your email address will not be published. Required fields are marked *

Authors

Michael Fralick

Co-director of the Rounds Table

Michael Fralick is a general internist at Mount Sinai Hospital in Toronto. He completed a Master of Science in Clinical Epidemiology at Harvard University, including a Research Fellowship in Health Policy at the Program On Regulation Therapeutics and Law (PORTAL). His PhD focused on the intersection between machine learning and pharmacoepidemiology.

John Fralick

Co-director

John Fralick is a general internist at Foothills Medical Centre in Calgary. He completed a Master of Science in Epidemiology at Queen’s University. He completed medical school at the University of Calgary and did his internal medicine training at the University of Toronto.

Kieran Quinn

Contributor

Kieran is a clinical scientist at the Sinai Health System.

Emily Hughes

Contributor

Emily is an Internal Medicine Resident at the University of Toronto Department of Medicine.

Republish this article

Republish this article on your website under the creative commons licence.

Learn more